Cash And Equivalent Cambiamento Data
ALKERMES USD 647.71M 18.08M 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pacira USD 153.3M 54.18M 2023-12
Supernus Pharmaceuticals USD 75.05M 19.93M 2023-12



Revance Therapeutics Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.